Skip to main content
. 2015 Apr 28;54(10):1043–1055. doi: 10.1007/s40262-015-0271-5

Fig. 4.

Fig. 4

Mean cumulative 14C-radioactivity recovery–time profiles after a single oral dose of 14C-enzalutamide (160 mg, 100 µCi) in the mass balance and biotransformation study(n = 6 healthy adult males). The majority of excretion of drug or drug-related product in urine was in the form of carboxylic acid metabolite